BiotechTube
Euclid Systems

Euclid Systems

Cambridge, United States· Est.
euclidlenses.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.8M

Overview

Euclid Systems is an established, commercial-stage private company focused on the high-growth myopia management market. Its core business model revolves around providing medical devices—specifically specialty contact lenses and diagnostic imaging equipment—to eye care practitioners. With a 30-year history and products used on over 2 million eyes, Euclid leverages a strong clinical research foundation and a practitioner-support ecosystem to drive adoption. The company aims to equip optometrists and ophthalmologists with tools and training to build profitable myopia management services, addressing a significant pediatric vision health epidemic.

Ophthalmology

Technology Platform

Specialty contact lens designs (Ortho-K and daily disposable) for myopia control, incorporating peripheral defocus optics. Integrated with corneal topography and imaging technology (Medmont Meridia) for fitting and management.

Funding History

1
Total raised:$2.8M
Seed$2.8M

Opportunities

The global myopia epidemic, particularly in children, creates a vast and growing addressable market.
Increasing awareness among parents and eye care professionals about the risks of progressive myopia is driving demand for management solutions.
Euclid's dual-product strategy (Ortho-K and daily lenses) and integrated diagnostic tool allow it to capture a wide range of patients and practitioner preferences.

Risk Factors

Intense competition from other lens manufacturers, pharmaceutical approaches (e.g., low-dose atropine), and new technologies.
Safety concerns related to overnight lens wear (Ortho-K), including risk of infection, could lead to regulatory scrutiny or negative publicity.
Market growth is dependent on the adoption rate by eye care practitioners, which requires investment in training and changing practice patterns.

Competitive Landscape

Euclid competes in the myopia management device space against other contact lens companies like CooperVision (MiSight® daily disposable lens) and Paragon Vision Sciences (CRT® Ortho-K lenses). It also faces indirect competition from pharmaceutical approaches (low-dose atropine drops) and general contact lens manufacturers. Euclid differentiates itself with its long history, strong clinical research foundation, integrated topographer system, and dedicated practitioner support ecosystem.

More companies in United States →